Scientists discovered why a 20-year-old breast cancer vaccine kept patients alive: it created long-lasting "memory" cells. The problem is that most cancer vaccines don't last long enough to stop the disease. The solution involves boosting a signal called CD27, which supercharges immune "helper" cells. This benefits people by potentially making future vaccines powerful enough to eliminate up to 90% of tumours, offering long-term survival for those with advanced cancer.
